Mebufotenin (Beckley Psytech)

N/A

Report date: 2025/01/14 11:38:46
NME

Base Information

Drug NameMebufotenin (Beckley Psytech)
Drug Alias Name5-Methoxy-N-N-DimethyltryptamineBPL-0035-MeO-DMT (Beckley Psytech)BPL-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulators
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandAustralia +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeckley Psytech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAtai Life Sciences NVBeckley Psytech Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A